Enzymically-mediated changes in murine mammary adenocarcinoma cell membrane induces changes in lymphoid tissue immune ribonucleic acids.
A cell suspension derived from a single murine spontaneous mammary adenocarcinoma was resolved on a linear gradient of Ficoll, into twelve distinct neoplastic cell subpopulation. A second cell suspension, also derived from a single murine mammary adenocarcinoma was first treated with vibrio cholera neuraminidase (VCN) then was resolved on an identical gradient of Ficoll into twelve distinct subpopulation. Each cell population was seeded and allowed to proliferate. The cell subpopulations differed in their doubling time, cloning efficiency, tumorigenicity and metastatic capacity. Although in vivo the murine spontaneous mammary adenocarcinoma (SMMAdCa) never metastasized, SMMAdCa-10 subpopulation metastasized into lymph nodes and lungs. All VCN-modified subpopulations were non-oncogenic. Cells from each population were used to immunize groups of syngeneic mice. The spleens of each group were pooled and Immune-RNA's were extracted with the phenol-water standard technique. The IRNA's preparations stimulated DNA synthesis in normal murine spleenocytes. The various I-RNA's differed in their biological activities, base composition and their sensitivity to ribonuclease.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000276:immunology; D000818:Animals; D002462:Cell Membrane / Q000187:drug effects*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D005260:Female; D007112:Immunity, Maternally-Acquired; D008214:Lymphocytes / Q000276:immunology; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology; D051379:Mice; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000494:pharmacology*; D012313:RNA / Q000276:immunology*; D013154:Spleen / Q000276:immunology; D014734:Vibrio cholerae / Q000276:immunology
D012313:RNA; D009439:Neuraminidase